Business Wire

CA-ZYNGA

8.4.2021 14:02:13 CEST | Business Wire | Press release

Share
Zynga Launches Modern Match-3 Mobile Game Puzzle Combat

Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced the worldwide launch of Puzzle Combat , a new mobile match-3 action role-playing game (RPG) where players recruit heroes, build bases and compete in player-vs-player (PvP) battles in a zombie-themed setting. Puzzle Combat is developed by Helsinki-based Small Giant Games , a subsidiary of Zynga Inc. and the studio behind the hit game Empires & Puzzles .

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210408005009/en/

In Puzzle Combat , players will immerse themselves in battling enemies from the dangerous Dread Army with power-ups by creating unique match combinations. Players recruit spies, medics, demolition experts and more to fight on their side, each bringing unique special attacks to the fray. Players will also design impenetrable bases by constructing and upgrading buildings like foundries, workshops, training schools and quarters.

Puzzle Combat gives players the rush of commanding the ultimate squad of heroes, all through the familiar fun of a match-3 experience,” said Jose Saarniniemi, Managing Director of Small Giant Games. “By combining key elements of Empires & Puzzles with a new, modern combat-themed game design, Puzzle Combat immerses players in a dynamic, action-packed virtual world filled with zombies. Following today’s release, we expect Puzzle Combat t o build a community of engaged gamers with additional themes and upgraded features designed to appeal to players around the world.”

Puzzle Combat matches players in PvP battles with other players around the world. To achieve combat dominance, players summon hundreds of individualized powerful heroes, each with unique abilities, and collect different weapons to upgrade and use in the field. As players progress, they can also join alliances to share best tactics and compete in challenging team events to promote their heroes, advance together and form the ultimate fighting force.

Key gaming highlights include:

  • More than 200 unique heroes for players to collect and upgrade.
  • Fast-paced match-3 action with special attacks unlocked by matching similar tiles in unique combinations.
  • Base-building designed to train your recruits into heroes, farm for food, mine metals, craft critical battle items and more.
  • Extensive PvP raid seasons with valuable rewards.
  • Cooperative alliance game modes to dismantle powerful war machines, attack rivals in team battles and dominate in team events.
  • Social features, such as global and alliance chats, allow players to exchange tactics and form teams to achieve the next level of gameplay.
  • Limited time events to earn unique rewards and compete against other players.

Puzzle Combat is available now for iOS and Android as a free download.

For more information, visit:
Facebook
Twitter
Instagram

Zynga will release its first quarter 2021 results after the close of the market on Wednesday, May 5, 2021.

Editor’s Note:

To view the supporting assets for Puzzle Combat, please click here .

About Zynga Inc.

Zynga is a global leader in interactive entertainment with a mission to connect the world through games. To date, more than one billion people have played Zynga’s franchises including CSR Racing™ , Empires & Puzzles™ , Merge Dragons!™ , Merge Magic!™ , Toon Blast™ , Toy Blast™ , Words With Friends™ and Zynga Poker™ . Zynga’s games are available in more than 150 countries and are playable across social platforms and mobile devices worldwide. Founded in 2007, the company is headquartered in San Francisco with locations in the U.S., Canada, the U.K., Ireland, India, Turkey and Finland. For more information, visit www.zynga.com or follow Zynga on Twitter , Instagram , Facebook or the Zynga blog .

FORWARD-LOOKING STATEMENT

This press release contains forward-looking statements, relating to, among other things, our expectations related to the launch of Puzzle Combat , including its launch and reception, adoption by players, game features and highlights, and overall growth opportunities. Forward-looking statements often include words such as “will,” “planned,” “intends,” “anticipate,” “believe,” “target,” “expect,” and statements in the future tense are generally forward-looking. The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Undue reliance should not be placed on such forward-looking statements, which are based on information available to us on the date hereof. We assume no obligation to update such statements. More information about these risks, uncertainties, and assumptions is or will be described in greater detail in our public filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained by visiting our Investor Relations website at http://investor.zynga.com or the SEC’s website at www.sec.gov .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye